MENU
+Compare
SMMT
Stock ticker: NASDAQ
AS OF
Aug 7, 04:59 PM (EDT)
Price
$28.07
Change
-$0.45 (-1.58%)
Capitalization
21.18B

SMMT Summit Therapeutics Forecast, Technical & Fundamental Analysis

Summit Therapeutics Inc is a biopharmaceutical company that focuses on the discovery, development, and commercialization of novel antibiotics for serious infectious diseases... Show more

Industry: #Biotechnology
SMMT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for SMMT with price predictions
Aug 06, 2025

SMMT's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for SMMT turned positive on August 05, 2025. Looking at past instances where SMMT's MACD turned positive, the stock continued to rise in of 48 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on August 01, 2025. You may want to consider a long position or call options on SMMT as a result. In of 106 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

SMMT moved above its 50-day moving average on July 08, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for SMMT crossed bullishly above the 50-day moving average on July 10, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where SMMT advanced for three days, in of 281 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 143 cases where SMMT Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for SMMT moved out of overbought territory on July 17, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 33 similar instances where the indicator moved out of overbought territory. In of the 33 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SMMT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

SMMT broke above its upper Bollinger Band on August 04, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. SMMT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (61.350) is normal, around the industry mean (18.047). P/E Ratio (26.355) is within average values for comparable stocks, (58.309). SMMT's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.504). Dividend Yield (0.000) settles around the average of (0.047) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (276.800).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

View a ticker or compare two or three
SMMT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

SMMT is expected to report earnings to rise 45.00% to -10 cents per share on November 05

Summit Therapeutics SMMT Stock Earnings Reports
Q3'25
Est.
$-0.10
Q1'25
Beat
by $0.02
Q4'24
Beat
by $0.01
Q3'24
Beat
by $0.02
Q2'24
Missed
by $0.03
The last earnings report on May 01 showed earnings per share of -7 cents, beating the estimate of -9 cents. With 711.50K shares outstanding, the current market capitalization sits at 21.18B.
A.I. Advisor
published General Information

General Information

a developer of novel medicines

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
601 Brickell Key Drive
Phone
+1 650 460-8308
Employees
105
Web
https://www.smmttx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
FHDG32.240.05
+0.17%
FT Vest U.S. Eq Qt Dyn Buffr ETF
PHB18.420.01
+0.05%
Invesco Fundamental Hi Yld® Corp Bd ETF
IPPP10.03N/A
N/A
Preferred-Plus ETF
LQDI26.43N/A
-0.02%
iShares Inflation Hedged Corp Bd ETF
DSTL54.98-0.08
-0.15%
Distillate US Fdmtl Stblty & Val ETF

SMMT and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, SMMT has been closely correlated with BCDA. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if SMMT jumps, then BCDA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SMMT
1D Price
Change %
SMMT100%
-2.09%
BCDA - SMMT
70%
Closely correlated
-5.52%
TIL - SMMT
55%
Loosely correlated
-2.52%
BNTX - SMMT
52%
Loosely correlated
+0.21%
RLAY - SMMT
47%
Loosely correlated
N/A
FHTX - SMMT
43%
Loosely correlated
-2.00%
More

Groups containing SMMT

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SMMT
1D Price
Change %
SMMT100%
-2.09%
SMMT
(2 stocks)
99%
Closely correlated
-1.67%